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Abstract
Background: Mitochondrial alternative respiratory-chain enzymes are phylogenetically widespread, and buffer
stresses affecting oxidative phosphorylation in species that possess them. However, they have been lost in the
evolutionary lineages leading to vertebrates and arthropods, raising the question as to what survival or reproductive
disadvantages they confer. Recent interest in using them in therapy lends a biomedical dimension to this question.
Methods: Here, we examined the impact of the expression of Ciona intestinalis alternative oxidase, AOX, on the
reproductive success of Drosophila melanogaster males. Sperm-competition assays were performed between flies
carrying three copies of a ubiquitously expressed AOX construct, driven by the α-tubulin promoter, and wild-type
males of the same genetic background.
Results: In sperm-competition assays, AOX conferred a substantial disadvantage, associated with decreased
production of mature sperm. Sperm differentiation appeared to proceed until the last stages, but was spatially
deranged, with spermatozoids retained in the testis instead of being released to the seminal vesicle. High AOX
expression was detected in the outermost cell-layer of the testis sheath, which we hypothesize may disrupt a signal
required for sperm maturation.
Conclusions: AOX expression in Drosophila thus has effects that are deleterious to male reproductive function. Our
results imply that AOX therapy must be developed with caution.
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Background
In the animal kingdom, the alternative mitochondrial re-
spiratory chain is widely represented, as illustrated by
the broad phylogenetic distribution of the gene for the
alternative oxidase (AOX) [1, 2]. AOX is a single-
subunit enzyme able to bypass respiratory complexes III
and IV, transferring electrons from ubiquinone to oxy-
gen without proton pumping and ATP production. It is
believed to buffer stresses affecting oxidative phosphor-
ylation, whether due to overload, environmental insults
or genetic damage. However, AOX, as well as other al-
ternative respiratory enzymes, was lost independently
during the early evolution of both vertebrates and ar-
thropods. This raises the question of what disadvantages
AOX might have conferred on the survival and/or re-
productive fitness of the ancestors of these taxa.
In fact, only marine invertebrates appear to still pos-
sess genes for alternative enzymes [1–3]. Nonetheless,
when the AOX gene from the tunicate Ciona intestinalis
(Ascidiacea) was expressed in cultured human cells, it
promoted resistance to inhibitors of complexes III and
IV [4] and compensated for the growth defects and
oxidant-sensitivity of complex IV-deficient cell-lines [5].
In the fruitfly Drosophila melanogaster, transgenic ex-
pression of C. intestinalis AOX had no apparent effect
on viability, reproduction and health of the organism [6].
It conferred resistance to otherwise lethal levels of com-
plexes III and IV inhibitors [6], mitigated locomotor de-
fects in the dj-1β Parkinson’s disease model [6] and
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ameliorated diverse phenotypes associated with complex
IV deficiency [7], defective mtDNA replication [8], or
expression of human β-amyloid [9]. C. intestinalis AOX
has also been successfully expressed in the mouse with-
out any significant effect on major physiological parame-
ters [10, 11]. It led to decreased production of reactive
oxygen species (ROS) when the respiratory chain was
blocked, was able to support cyanide-resistant respir-
ation by intact organs, and conferred prolonged protec-
tion against lethal concentrations of hydrogen cyanide in
whole animals [10, 11].
These benefits of AOX expression raise the possibility
of its eventual use for treatment of human patients with
complexes III and/or IV deficiencies, as a by-pass ther-
apy [12]. However, the advantages of AOX expression in
‘higher’ animal systems under pathological conditions
contrasts with its evolutionary loss from the genome of
vertebrates and arthropods. A detailed study of the biol-
ogy of the alternative pathways is therefore required be-
fore any use of this enzyme in gene therapy for
mitochondrial or neurodegenerative disorders can be
contemplated [13].
We set out to investigate the paradox between the
beneficial by-pass and the possible maladaptive conse-
quences of AOX expression in higher metazoans, by dir-
ectly testing its effects on male reproductive function.
Sperm are highly dependent on biological energy. There-
fore, we reasoned that it may be a relevant target in
which to test for subtle but functionally meaningful det-
riments of AOX expression. We challenged D. melano-
gaster males expressing AOX in competition assays with
AOX-nonexpressors. AOX produced a clear impairment
to reproductive function that was associated with de-
creased production of mature sperm cells. This suggests
that possible gene therapy applications of AOX must be
developed with caution.
Results
Males expressing AOX are defective in sperm-competition
assays
In Drosophila, as in many species, females typically mate
with a succession of males, storing sperm inside the fe-
male body to fertilize oocytes as they mature [14]. Sperm
competition occurs by means of a substitution mechan-
ism, in which a second male dislodges the sperm of the
first male from the female’s reproductive tract and re-
places it with its own gametes [14, 15]; this is apparently
the motive force for the correlative evolution between
the male’s giant sperm cells and the female’s spacious
sperm-storage organs [16]. Newly acquired sperm com-
petes with and usually displaces that from previous
males, unless it is functionally compromised. These
mechanisms can drive evolution by maximizing male re-
productive success, such as by the development of larger
testes, production of more abundant, more viable or
longer-lasting gametes, or by modifying the response to ele-
vated competition risk, among other characteristics [17].
To test the reproductive success of D. melanogaster
males expressing AOX, we performed sperm-
competition assays between flies carrying three copies of
the α-tubulin-AOX construct, as described previously
(3Xtub-AOX line: genotype tub-AOX35/Y; tub-AOX112/
tub-AOX112; tub-AOX7/tub-AOX7 [7]) and wild-type
males of the same genetic background (w1118). In the
‘defensive’ approach, 3Xtub-AOX males were first
allowed to mate with virgin w1118 females, which were
then mated with w1118 males in the absence of 3Xtub-
AOX males. Progeny from the competing males can be
distinguished by eye-colour: those from transgenic males
have red eyes, whilst those from w1118 males have white
eyes. Controls consistently show that the eye-colour
marker, as such, has no influence over the outcome
(Additional file 1: Fig. S1).
The number of progeny originating from the sperm of
3Xtub-AOX males was decreased after the females were
mated subsequently with w1118 males (Fig. 1a, upper
panel). This result is consistent with previously pub-
lished data using diverse genetic backgrounds [14, 18–
21] and with our own data using several other trans-
genes (Fig. 1b, Additional file 1: Fig. S1–S3): sperm of
the first male is replaced (partially or completely) by the
sperm of the second male. To implement a rigorous stat-
istical analysis of the findings, we derived the parameter
P1’ which measures the proportion of progeny sired by
the first male to mate in sperm-competition assays [22].
This was similar for all lines analyzed here, although
3Xtub-AOX males sired statistically fewer offspring than
some of the AOX-nonexpressor controls (Additional file
1: Table S1).
In contrast, when 3Xtub-AOX males were challenged
in an ‘offensive’ approach, i.e., when the virgin w1118 fe-
males were first crossed with w1118 males, then with
AOX-expressing males, the number of 3Xtub-AOX pro-
geny never overcame the number of w1118 progeny (Fig.
1a, lower panel). In fact, even after 10 days since w1118
males were removed from the mating vials, eggs fertil-
ized with the original male sperm were still preferentially
laid over the ones fertilized with 3Xtub-AOX sperm (Fig.
1a, lower panel, vial IV). Control experiments performed
with red-eyed daughterless-GAL4 (daGAL4) (Fig. 1b,
lower panel) and tubulin-GeneSwitch (tubGS) and also
UAS-empty2nd and UAS-empty3rd (Additional file 1: Fig.
S1) males imply that the failure of AOX-expressing
males to compete successfully in the offensive paradigm
is specific to AOX, and is not a property of transgenic
lines in general. The defect appeared to be AOX
transgene-dose dependent. Males carrying only two cop-
ies of the tub-AOX transgene (Additional file 1: Fig. S2)
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appeared less impaired in the ‘offensive’ paradigm than
those carrying three (Fig. 1a), whilst those with just a
single copy of tub-AOX were not significantly different
from control males (Additional file 1: Fig. S2). These
conclusions reflect the statistical analysis of the propor-
tion of progeny sired by the second male (P2’, [22]),
wherein 3X and 2Xtub-AOX males were significantly im-
paired in the offensive paradigm compared to all control
classes (Additional file 1: Table S2), although the differ-
ences between 3X and 2Xtub-AOX (Additional file 1:
Table S2) themselves were not significant. The observed
phenotypes also correlate approximately with the
amount of expression of the tub-AOX transgene in the
male reproductive system, observed by immunoblotting
(Additional file 1: Fig. S4).
However, expressing GAL4-dependent UAS-AOX
using the daGAL4 driver [6], produced no loss of
sperm-competitiveness (Additional file 1: Fig. S3A, and
Table S2), despite the fact that the level of AOX protein
in the male reproductive system was comparable with
that expressed from multiple copies of tubAOX (Add-
itional file 1: Fig. S4). These data suggest that the effect
of AOX on sperm competitiveness depends on the
precise cellular context of its expression rather than sim-
ply its overall amount.
AOX-expressing males accumulate a decreased amount of
mature sperm
Successful sperm competition in Drosophila depends
both on the number and quality of spermatozoids and
on the compatibility between the male’s seminal fluid
proteins and their receptors in the female reproductive
tract [17, 23–25]. We checked how the production of
mature spermatozoids in the 3Xtub-AOX males is af-
fected by dissecting the reproductive organs in adult
males of increasing age. Spermatogenesis in D. melano-
gaster starts at the distal tip of the testes, taking place in-
side cysts. As cell differentiation proceeds, the cysts
move towards the proximal end of the testes, where
these organs connect to the SVs. The mature spermato-
zoids are then deposited in the SVs, where they are
stored until mating [26]. Therefore, as adult males age,
the testes tend to get thinner, because differentiation in
the cysts proceeds and the fully formed spermatozoids
move to the SVs, which in turn increase in size. As
shown in Fig. 2 (panels a and c), the thickness of the
Fig. 1 AOX-expressing males are defective in sperm-competition assays. In the defensive paradigm (upper panels), virgin w1118 females (white
eyes) were initially crossed individually with transgenic males (red eyes), and then with w1118 males (white eyes). In the offensive paradigm (lower
panels), the virgin w1118 females were first crossed with w1118 males, and then with transgenic males (see Methods for details). The transgenic
males used were 3Xtub-AOX (tubAOX35/Y; tubAOX112/tubAOX112; tubAOX7/tubAOX7) in a, and daGAL4 (X/Y; 2/2; daGAL4/daGAL4) in b. Vials I-IV repre-
sent the mean number of white- or red-eyed progeny ± SD (error bars), eclosed after 3 days from the initial crosses (vial I), 3 days of egg-laying
during second crosses (vial II), 3 days of oviposition only, subsequent to second crosses (vial III, males discarded), followed by 5 days of further
oviposition (vial IV)
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testes of control flies decreases >50% in the first 10 days
of adult life, whereas the SVs triple in size. In contrast,
the testes of 3Xtub-AOX males exhibit a much less
pronounced decrease in thickness (~25%), whilst at the
same time their SVs remain immature. In addition, we
observed an accumulation of whitish material at the
A
B
C
Fig. 2 Mature sperm cells do not accumulate in the seminal vesicles (SVs) of AOX-expressing males. Representative samples of dissected testes and SVs
from adult males of the indicated age are shown for control and AOX-expressing lines: a w1118 (X/Y; 2/2; 3/3) and 3Xtub-AOX (tubAOX35/Y; tubAOX112/
tubAOX112; tubAOX7/tubAOX7); b UAS-AOXF6/w1118 (X/Y; UAS-AOXF6/2; 3/3) and UAS-AOXF6/tubGS (X/Y; UAS-AOXF6/2; tubGS/3) in the absence (uninduced) or
presence (induced) of 200 μM mifepristone. AOX protein induction by mifepristone was visualized by immunoblotting (Additional file 1: Fig. S5). Red
circles indicate one of the dissected SVs of the representative samples of the indicated genotype. Note the underdeveloped state of the SVs in 10 day-
old flies from the lines expressing AOX either constitutively (3Xtub-AOX) or inducibly (UAS-AOXF6/tubGS plus mifepristone). For an explanatory visualization
of D. melanogaster reproductive organs, see Additional file 1: Fig. S6A. In a, the inset highlights the whitish material that accumulates in the proximal end
of the testis in 3Xtub-AOX males; in b, the red arrow points to the same material for UAS-AOXF6/tubGS males treated with mifepristone. c Quantification of
the data shown in a and b, in which the data points represent the mean thickness of 10–20 dissected organs ± SD (error bars). * indicates statistically
significant difference between organs of AOX-expressing and nonexpressing males (p ≤ 0.01). Additional file 1: Fig. S8B illustrates schematically the
thickness measurement protocol used to estimate the amount of immature (in the testes) and mature (in the SVs) sperm cells per fly
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proximal end of the testes of 10-day-old 3Xtub-AOX
males (Fig. 2a, inset), which we investigated further (see
below). The mature spermatozoids produced by these
males, although few in number, did not appear to have
any motility defects, as judged by visual inspection.
We were able to produce a similar phenotype using
the inducible GeneSwitch (tubGS) system, in which the
same α-tubulin promoter as used in the tub-AOX con-
structs controls the expression of a modified GAL4 that
is inducible by mifepristone (RU486). This allows time-
regulated expression of a GAL4-dependent AOX trans-
gene in exactly the same tissues as in the tubAOX lines.
By transferring males to food-vials containing the indu-
cing drug on the day of eclosion, any possible develop-
mental disturbance is avoided, whilst accurate controls
can be implemented, notably flies with transgene, but
lacking driver and/or drug (see Additional file 1: Fig. S5
for immunoblots indicating tight regulation of AOX pro-
tein levels using this system). Similarly as for 3Xtub-
AOX males, the testes of UAS-AOX transgenic males
driven by tubGS in the presence of mifepristone
remained thick during the first 10 days of adult life,
whilst their SVs remained small (Fig. 2b and c). These
organs were as wild-type in the absence of the driver or
inducing drug (Fig. 2b and c). The normal thinning of
the testis over the first 10 days of adult life was also seen
when both the driver and inducing drug were present,
whether driving a control transgene, GFP, a catalytically
inactive form of AOX, mutAOX [27] or even with no
transgene at all (Additional file 1: Fig. S6A, S6C). In
these cases, however, the SV remained undeveloped, but
only when driver and drug were both present (Add-
itional file 1: Fig. S6B, S6D). The whitish material near
the proximal end of the testis also accumulated promin-
ently when tubGS was used to express AOX (but not
GFP or mutAOX), and again only under inducing condi-
tions (Fig. 2b, red arrow). To confirm that this is an α-
tubulin promoter-specific phenotype, we dissected the
reproductive organs of 10-day-old males expressing
UAS-AOX driven by daGAL4. The SVs had a normal
morphology (Additional file 1: Fig. S7), and appeared to
have accumulated a similar amount of mature sperm
cells as controls, in agreement with the results of the
sperm-competition assays (Additional file 1: Fig. S3).
Other reproductive organs were also evaluated mor-
phologically (see Additional file 1: Fig. S8A for sche-
matics of the reproductive system of D. melanogaster
males), but no obvious alterations were observed be-
tween AOX-expressing and control males, based on vis-
ual inspection of >70 dissected flies of each genotype.
Although AOX was not expressed in the accessory
glands (Additional file 1: Fig. S9A), we also checked the
presence of Sex Peptide in these organs by immuno-
staining and confocal microscopy, and again observed
no difference (Additional file 1: Fig. S9B). Sex Peptide is
one of the most important components of the male’s
seminal fluid; it has been implicated in reproductive suc-
cess in sperm-competition assays [24, 28] and its action
is dependent on the compatibility with receptors in the
female reproductive tract [23]. Altogether, our data indi-
cate that AOX-expressing males are defective in sperm-
competition assays due to a decreased production of ma-
ture spermatozoids.
AOX is expressed in cells of the testis and seminal vesicle
sheaths
Although the SVs of AOX-expressing males present per-
haps the most pronounced phenotype in our study, these
are purely storage organs for mature sperm cells [26],
and their morphology was not diagnostic for AOX ex-
pression (Additional file 1: Fig. S6B).
Therefore, we hypothesized that the defect in sperm
production caused by AOX expression most likely af-
fects the testes, where spermatogenesis takes place. The
α-tubulin promoter has been used previously to drive
transgene expression in the fly testis in both somatic
cells and the germline (from the stem-cell stage to late
spermatocytes, reviewed in [29]). However, using im-
munofluorescent confocal microscopy (Fig. 3 and Add-
itional file 1: Fig. S10), AOX expression from the α-
tubulin promoter, whether directly (Additional file 1:
Fig. S10) or driven by tubGS plus mifepristone (Fig. 3),
was below the level of detection in germline cells, and
seen only at very low levels in some somatic cyst cells.
Nevertheless, it was abundantly expressed in the somatic
cells of the testis and SV sheaths. In addition, all of the
immature stages of cell differentiation appeared to be
present (Additional file 1: Fig. S11), judging by the char-
acteristic changes in nuclear morphology, mitochondrial
network arrangement and cellular elongation that the
germ line cells go through towards the final steps in
spermatogenesis [26].
At higher resolution, it was clear that not all cells in
the ensheathing tissues of the testes and SVs express
AOX at a high level when driven by the α-tubulin pro-
moter (either directly, as 3Xtub-AOX or indirectly,
through tubGS). Some cells highly expressing ATP5A, a
complex V subunit traditionally used as a mitochondrial
marker, appeared negative for AOX (Additional file 1:
Fig. S12A). Using UAS-StingerGFP in combination with
the tubGS driver, in order to mark the positive cells with
GFP in the nucleus, we observed high expression in spe-
cific cells in the outermost sheath-cell layer (Additional
file 1: Fig. S12B). The inner sheath-cell layer, formed of
smooth-muscle cells with multiple small nuclei, ap-
peared negative for AOX or GFP, in agreement with co-
staining for AOX and actin (Additional file 1: Fig. S13A)
in the testes of 3Xtub-AOX males. Positive cells most
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likely correspond with the pigment cells, which carry a
single large nucleus, and are abundant around the SVs
and the proximal end of the testis, where these two or-
gans connect [30]. This is supported (Additional file 1:
Fig. S13B–D) by co-staining for the empty spiracles gene
product (ems), which is a marker for the pigment cells
[31, 32]. Partial three-dimensional reconstruction of the
microscopy images shows that the AOX and ems signals
are located in the outermost cell layer of the sheath of
the SV (Additional file 1: Fig. S13C) and testis (Add-
itional file 1: Fig. S13D), whilst the underlying (smooth
muscle) cells stain highly for ATP5A and actin. Note
that the pigment cells are abundant in the anatomical
region where the most pronounced morphological alter-
ations were found in AOX-expressing males, marked by
the accumulation of whitish material at the proximal
end of the testis combined with a decreased amount of
mature sperm cells in the SVs (Fig. 2a).
Mature-looking spermatozoids are lodged in the proximal
end of the testis in AOX-expressing males
The proximal end of the D. melanogaster testis is also
the region where the individualization process starts.
This process is essential for the final stage of elongated
spermatid differentiation [26], and is accomplished by an
individualization complex (IC) that is assembled in the
cyst region containing the spermatid nuclei and which
then moves towards the tip of the tails, collecting synci-
tial cytoplasm and creating cystic bulges and waste bags
(WBs) along the way [33, 34]. By staining the testis sam-
ples for actin and activated caspase-3, two components
of the ICs, we observed no significant differences in the
number of starting and established ICs in males express-
ing AOX driven by tubGS, but did observe an elevated
number of WBs (Additional file 1: Fig. S14). Most no-
ticeably, we observed in these males a dramatic change
in the distribution of ICs throughout the organ. Starting
ICs are usually present in the proximal region of the
testis, but in 10 day-old males expressing AOX driven
by tubGS, a significant number of them were found to-
wards the middle region of the organ. Established ICs,
which are usually found all along the testes, were con-
centrated at the middle and proximal end of the AOX-
expressing testes. Finally, WBs appeared to be distrib-
uted in all testis regions in the AOX-expressing males,
whereas in control testes they accumulated at the distal
end (Additional file 1: Fig. S14C). Our observations
imply that AOX expression driven by tubGS in the
Fig. 3 AOX protein is localized in mitochondria of cells from the testis and seminal vesicle (SV) sheaths. Immunoflorescence staining and confocal
microscopy for the indicated proteins and DAPI, from a 10-day old male of genotype X/Y; UAS-AOXF6/2; tubGS/3, in the presence of mifepristone. AOX
protein is localized to the outermost cell layer of these organs, where it overlaps that for the mitochondrial marker ATP5A, but not to germline cells at
any stage of differentiation. The light microscopy image (left) is from a control male (w1118), used for illustration purpose only. Spermatogenesis takes
place inside cysts, starting at the tip of the testes (upper panels - note the concentration of nuclei that represent the first stages of this process) and
moving towards the proximal end of the organ as cell differentiation proceeds (middle panels - note the presence of a cyst containing onion-stage
spermatids with their single mitochondrial mass, called the Nebenkern). At the proximal end of the testis, mature spermatozoid cells are released from
the cyst and stored in the SV (lower panels - note the needle-shaped nuclei that is typical of these cells). Note also the low-level AOX expression in the
somatic cells of the cysts, but not in the germline. See Additional file 1: Fig. S10 for comparable images from 3Xtub-AOX males
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somatic cells of the cysts, and/or in the pigment cells
of the testis sheath causes internal rearrangements in
this organ, disrupting the production and delivery of
mature sperm.
To investigate the nature of the whitish material found
at the proximal end of the testis of AOX-expressing
males, we used a transgenic construct that expresses
GFP-tagged Don Juan protein (DJ-GFP) in the tail of
elongated spermatids and mature spermatozoids [35,
36], enabling us to evaluate the transition between these
two stages. The expression of DJ-GFP revealed a high
concentration of what appeared to be individualized ma-
ture spermatozoids in the proximal end of the testis of
AOX-expressing males (Fig. 4, lower panels). In control
males, few of these individualized GFP-positive cells
were found in this region of the testes (Fig. 4, upper
panels), as expected, given that they should move to the
SVs after individualization. The failure of the individual-
ized, elongated spermatids to move into the SV and the
associated disturbance in the spatial distribution of ICs
could account for the accumulation of the whitish ma-
terial seen by light microscopy, and is the simplest ex-
planation for the defect seen in sperm-competition
assays, although the reason why they are retained in the
testis is not obvious morphologically.
Discussion
In previous studies [6, 7] we reported that constitutive
expression of C. intestinalis AOX in Drosophila did not
affect viability or fertility under non-competitive lab
conditions. Here we demonstrate that transgenic AOX
expression in Drosophila under the α-tubulin promoter
does cause a clear detriment to male reproductive suc-
cess, using a stringent sperm-competition assay. This
was accompanied by a decreased and disorganized
production of mature spermatozoids. Although some
sperm cells appear to complete the process of mor-
phological differentiation, following individualization
they appear to remain lodged in the proximal region
of the testis, in the outer sheath of which AOX is
highly expressed.
AOX, when expressed directly under the α-tubulin
promoter or via the tubGS driver, is present at high
abundance in the pigment cells of the testis sheath and
SV, and is also found at very low levels in some somatic
cyst cells. However, it is below the level of detection in
the germline. The α-tubulin promoter has been reported
to drive germline expression of transgenes up to the late
spermatocyte phase [29]. Clearly, this does not apply to
the construct we used [7]. Surprisingly we also observed
no abnormalities during spermatogenesis in the mito-
chondrial network (Additional file 1: Fig. S11), the
reorganization of which provides the structural platform
for sperm axoneme formation [37]. On the other hand,
the elevated number and altered distribution of WBs in
the testes of AOX-expressing males may reflect in-
creased recycling of dysfunctional germ cells, where dif-
ferentiation has failed. We posit that the specific
disturbance in spermatogenesis produced by AOX ex-
pression is most likely due to deranged signaling from
somatic cells, rather than low-level AOX expression in
the germline itself.
The precursor cells of the testis and SV sheaths have
two distinct developmental origins: the pigment cells
originate in the gonad imaginal disc, along with the tes-
tes, whereas the muscle cells and the SVs originate in
the genital disc [38, 39]. When the two organs start fus-
ing, migration of pigment and muscle cells proceeds in
opposite directions with the gonad and the SVs each ac-
quiring an outer layer of pigment cells and an inner
Fig. 4 Individualized sperm cells remain lodged in the testes of AOX-expressing males. Fluorescence imaging of testes of 10-day old males of geno-
type X/Y; UAS-AOXF6/2; tubGS/DJ-GFP, under uninduced (upper panels) and mifepristone-induced (lower panels) conditions, was performed using
phalloidin-TRITC to detect actin and the DJ-GFP fluorescence to detect the tails of elongated spermatids and mature spermatozoids. Note that in the
proximal region of the testis (fluorescent confocal images, right, and red boxes on the white-light microscopy images, left) of the uninduced control
sample (AOX-nonexpressor) only the bundles of not-yet-individualized elongated spermatids are observed, whereas in the same region in AOX-
expressing males these cells appear individualized, tangled and/or disorganized, accounting for the accumulated whitish material shown in Fig. 2
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layer of muscle [30]. The failure to produce pigment
cells during development is known to lead to aberrant
muscle-cell migration, causing abnormal testis morph-
ology and male sterility, without affecting the germline
or somatic cell-types that support spermatogenesis [30].
This interdependent migration implies the existence of a
signaling network between the pigment and the muscle
cells. Our findings suggest that communication between
these cell-types might continue after testis development is
complete. We suggest that AOX expression in the pigment
cells might in some way disrupt their ability to deliver sig-
nals required for the completion of spermatogenesis, and/
or to signal muscle contraction needed to guide individual-
ized mature spermatozoids from the proximal end of the
testis into the SV, leading to the accumulation of cysts in
late stages of maturation throughout the testis. This is sup-
ported by the fact that a low percentage of testes of 3Xtub-
AOX males (~5% of total testes analyzed, Additional file 1:
Fig. S15) presented malformations very similar to those re-
ported for males unable to develop pigment cells [30]. Al-
though the majority of testes are morphologically normal in
most 3Xtub-AOX males at eclosion, they remain thick over
the first 10 days of adult life (Fig. 2B), indicating a func-
tional defect in sperm production and delivery that would
be sufficient to account for the decreased reproductive suc-
cess under competitive conditions (Fig. 1). To prove that
AOX expression in the sheath pigment cells was the cause
of the observed sperm and reproductive defects would re-
quire a driver that enables its expression specifically in
these cells. Since no such driver is currently available, we
must rely instead on the strongly suggestive correlations we
have documented here.
The effect of AOX on cell-cell communication could
result from one of several metabolic disturbances con-
ferred by the enzyme. If constitutively activated by local
metabolic conditions in specific cells, AOX could par-
ticipate significantly in respiratory electron flow, impair-
ing ATP production or other downstream processes
dependent on respiratory energy, such as the buffering
of calcium (reviewed in [40]). A calcium signaling path-
way has been implicated in the upregulation of Wnt-2
[41], which regulates differentiation in many cellular
contexts, including the testis pigment cells during Dros-
ophila development, promoting muscle cell migration
and attachment [30]. Drosophila males mutant for Wnt-
2 are sterile due to severe testis malformations [30],
whereas males expressing AOX are fertile and appear
morphologically normal at eclosion, with a functional
defect only revealed by a stringent competition assay
and by the apparent retention of sperm within the testis
during the first 10 days of adult life.
An interference with cell signaling may also involve
ROS. AOX has been reported to decrease mitochondrial
ROS production even under conditions of normal
oxidative phosphorylation activity [6, 42]. In either case,
the very subtle phenotype, with all other physiological
and developmental functions apparently unaffected, pre-
sents a challenge for understanding the mechanism.
Clearly, much remains to be learned about the physio-
logical effects of AOX expression. Our findings indicate
the importance of studying these effects and their mech-
anisms in detail, before implementing AOX in gene ther-
apy. Some of its properties may need to be modified,
before the enzyme can be safely deployed.
Conclusions
AOX offers a potential therapeutic strategy for buffering
pathological stresses in mitochondria. Whilst it is, in-
deed, able to compensate for a number of pathological
insults, it has remarkably little, if any effect on normal
physiology of model organisms, including Drosophila.
Transgenic flies ubiquitously expressing AOX were earl-
ier found to exhibit normal development, reproduction
and lifespan.
In the present study we took this analysis to a deeper
level, by applying a more stringent test of reproductive
capacity, the well-established sperm-competition assay.
Despite being fertile, AOX-expressing males showed a
specific detriment in this test, which correlates with total
transgene expression dose. Morphologically, we found
this to be correlated with spatially deranged spermato-
genesis and failure to release mature sperm into the
storage organ (seminal vesicle) in normal quantities, al-
though the defect is inferred to arise in the somatic pig-
ment cells of the testis, not the germline. This is the first
demonstration of a developmental defect caused by
AOX expression in a metazoan, and needs also to be
taken into account when considering therapeutic uses of
AOX in humans.
Methods
Fly stocks and maintenance
Standard lines w1118, CyO and TM3,Sb balancers, UAS-
StingerGFP, daGAL4, tubGS, and DJ-GFP were obtained
from stock centres. The lines UAS-AOXF6 [6], tub-
AOX35, tub-AOX112, tub-AOX7, 2Xtub-AOX, 3Xtub-
AOX [7], UAS-AOXwt8.1, UAS-AOXmut, UAS-empty2nd,
and UAS-empty3rd [27] were described previously. All fly
lines were backcrossed into the w1118 background for
six-to-ten generations, and were maintained in standard
diet at 25 °C [6]. RU486 (mifepristone, Sigma, USA) was
added to the diet at the indicated concentrations for in-
duction of transgene expression using the tubGS line.
Sperm-competition assays
Sperm-competition assays were conducted using two ap-
proaches. In the defensive paradigm, approximately 50
virgin w1118 females (white eyes), aged between 3 and
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7 days, were initially allowed to mate individually with
5–8 day-old (virgin) transgenic males (red eyes, w+) for
3 days. The males were discarded and the females trans-
ferred to new vials and allowed to mate individually with
5–8 day-old w1118 males (white eyes), for a further 3 days,
after which the second males were also discarded. The
females were again transferred to new vials, allowed to
lay eggs for 3 days, then transferred finally for further
egg laying over 5 days. In the offensive paradigm, ap-
proximately 50 virgin w1118 females (white eyes) were
first crossed with w1118 males (white eyes), and then with
transgenic males (red eyes, w+), following the same mat-
ing and egg laying scheme of the defensive paradigm.
Reproductive success was measured by counting the
number of red- and white-eyed progeny, which repre-
sent, respectively, the progeny of transgenic and w1118
males. The small number of vials derived from any sin-
gle female that contained progeny exclusively of one eye
colour were considered to represent only a single mating
and were excluded from the analysis. Data were plotted
as mean number of progeny per female of each eye
colour, in the four successive mating/egg laying vial sets,
± standard deviation.
Dissection and imaging of male reproductive organs
Reproductive organs were dissected by anesthetizing
males of the indicated age and genotype with CO2 prior to
transferring to a dissection board containing phosphate-
buffered saline (PBS). Using thin dissection forceps, the
internal organs were removed from the abdomen by dis-
locating the external genitalia, followed by manual isola-
tion of the reproductive organs, which were imaged
immediately using the Nikon SMZ 745 T system under
white light. The images were analyzed and testis and SV
thickness was measured using NIS Elements D4.20 soft-
ware (Nikon Instruments Software, Netherlands).
For immunofluorescence imaging, dissected organs
were fixed in 4% paraformaldehyde for 20 min at room
temperature, and then transferred to PBS prior to
permeabilization. The organs were rinsed twice with
PBS containing 0.1% Triton X-100 and 0.1% BSA, then
permeabilized and blocked with PBS containing 1% Tri-
ton X-100 and 1% BSA for 30 min at room temperature,
followed by overnight incubation at 4 °C with the pri-
mary antibody diluted in PBS containing 0.3% Triton X-
100 and 0.5% BSA. The samples were then rinsed twice
and washed three times (30 min each) with PBS contain-
ing 0.1% Triton X-100 and 0.1% BSA at room
temperature, followed by overnight incubation at 4 °C
with the secondary antibody diluted in PBS containing
0.3% Triton X-100 and 0.5% BSA. Washes were per-
formed as described above, and samples were rinsed
with PBS and then Milli-Q water, prior to transferring to
optically clear 35 mm glass bottom dishes (MatTek,
USA) containing ProLong Gold Antifade Mounting
medium with DAPI (Molecular Probes, Life Technolo-
gies). Primary antibodies used were rabbit polyclonal
anti-AOX (1:10,000, [6]), mouse monoclonal anti-
ATP5A (1:1000, Abcam, UK), rabbit polyclonal anti-
activated caspase-3 (1:200, Cell Signaling Technology,
USA), rabbit polyclonal anti-Sex Peptide (1:300, gift from
Dr. Shanjun Chen) and rabbit polyclonal anti-empty spi-
racles (1:400, Antibody Verify, USA). Fluorescent sec-
ondary antibodies were Alexa 488-conjugated goat anti-
rabbit IgG (1:1000) and Alexa 568-conjugated gat anti-
mouse IgG (1:1000) (Fisher Scientific, USA). Actin was
stained using phalloidin-TRITC (1 μg/ml, Sigma, USA).
Samples were imaged using an Andor Spinning Disc or
Zeiss LSM 780 laser-scanning confocal microscope, re-
spectively with Andor iQ 3.0 or ZEN 2011 SP3 (black edi-
tion) software. Images were analyzed with ImageJ software
(National Institutes of Health, USA). No signals were ob-
served when the primary antibodies were omitted.
Immunoblotting
Protein extracts from whole adult males (20–30) and
from dissected testes and SVs of 50–100 males were pre-
pared by gentle grinding of tissues in 50–200 μl PBS
containing 1.5% Triton X-100 and Complete, Mini,
EDTA-free Protease Inhibitor Cocktail (Roche,
Switzerland). The suspension was centrifuged at 16,000
gmax for 10 min at 4 °C, and supernatant protein concen-
tration was measured by the Bradford method. Crude
mitochondrial preparations were obtained by homogen-
izing 50–100 adult males in ice-cold isolation buffer
(250 mM sucrose, 5 mM Tris, 2 mM EGTA, pH 7.4)
followed by centrifugation at 200 gmax for 3 min at 4 °C.
The supernatant was transferred to a new tube and cen-
trifuged at 9000 gmax for 10 min at 4 °C. The pellet was
resuspended in 50 μl of isolation buffer, and protein con-
centrations were determined using the Bradford method.
100 μg of total protein extracts and 40 μg of mitochon-
drial preparations were mixed with 5× Laemmli buffer
(10% SDS, 50% glycerol, 25% 2-mercaptoethanol, 0.02%
bromophenol blue and 0.3125 M Tris-HCl, pH 6.8), dena-
tured at 95 °C for 5 min and resolved by SDS-PAGE on
4–20% or Any kD Criterion Precast Gels (Bio-Rad) at
120 V for approximately 1.5 h. Proteins were transferred
to nitrocellulose membranes using the iBlot Gel Transfer
system (Invitrogen, USA) for 7 min at room temperature.
Membranes were blocked in TBST (0.15 M NaCl, 50 mM
Tris-HCl, 0.05% Tween 20, pH 7.6) containing 5% dried
nonfat milk for 2 h at room temperature or overnight at
4 °C. Primary antibodies (rabbit polyclonal anti-AOX
[1:10,000, [6]], mouse monoclonal anti-ATP5A [1:5000,
Abcam, UK], mouse monoclonal anti-PDH E1α [1:5000,
Abcam, UK], and mouse monoclonal anti-GAPDH
[1:5000, Abcam, UK]) were incubated for at least 1 h at
Saari et al. BMC Developmental Biology  (2017) 17:9 Page 9 of 11
room temperature, followed by three washes (10 min each)
with TBST. Secondary antibodies (HRP-conjugated goat
anti-rabbit and anti-mouse IgGs [1:10,000, Bio-Rad, USA])
were incubated for at least 2 h at room temperature, and
washed as described. Membranes were incubated in Lumi-
nol substrate detection system Immun-Star HRP (Bio-Rad,
USA), and chemiluminescence signals were detected on Fuji
Medical X-ray films (Fujifilm, Japan). Band densitometry
was performed with ImageJ software (National Institutes of
Health, USA).
Statistical analyses
Measurements of organ thickness were performed as sche-
matized in Additional file 1: Fig. S8B and tested for statis-
tical differences among the indicated groups of fly males
using one-way ANOVA with Newman-Keuls post hoc test.
For analysis of sperm-competition assays, the parameters
P1’ and P2’ [22] were tested for statistical differences among
the indicated groups of fly males, using one-way ANOVA
with Tukey post hoc test. The analyses were performed
using Prism software, version 5 (GraphPad Software, USA).
Additional file
Additional file 1: Table S1. Proportion of progeny sired by the red-
eyed male when this is the first male to mate in sperm competition
assays against w1118 males (P1´). Table S2. Proportion of progeny sired by
the red-eyed male when this is the second male to mate in sperm
competition assays against w1118 males (P2´). Figure S1. The sperm of
eye-color control and tubGS males shows normal competitive properties.
Figure S2. The defect in sperm-competition assays is AOX dose-
dependent. Figure S3. AOX expressed under the daughterless promoter
does not decrease sperm competitiveness. Figure S4. AOX protein levels
in testes and seminal vesicles of diverse AOX-expressing lines. Figure S5.
Induction of AOX expression using the UAS-AOXF6/tubGS system. Figure
S6. Altered testis morphology during adulthood is diagnostic for AOX
expression. Figure S7. Mature sperm cells accumulate normally in the
seminal vesicles (SVs) of males expressing AOX under the control of the
daGAL4 driver. Figure S8. Schematic diagrams and light microscopy of D.
melanogaster male reproductive organs [43]. Figure S9. AOX is not
present in the accessory glands and does not interfere with Sex Peptide
production. Figure S10. AOX protein is localized in mitochondria of cells
from the testis and seminal vesicle (SV) sheaths in 3Xtub-AOX males. Fig-
ure S11. Nuclear and mitochondrial morphologies in germline cells are
not altered in 3Xtub-AOX males. Figure S12. AOX is expressed in the
outermost cell layer of the testis and SV sheaths. Figure S13. AOX local-
izes to the pigment cell layer of the testis and SV sheaths of 3Xtub-AOX
males [44]. Figure S14. AOX-expressing males present alterations in sub-
testicular structures. Figure S15. Testis malformation in 3Xtub-AOX males.
(PDF 3255 kb)
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